Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
Completed
360 enrolled
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Phase 1 Completed
32 enrolled
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia
Completed
418 enrolled
Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496
Completed
175 enrolled
DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia
Completed
49 enrolled
Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia
Completed
137 enrolled
Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer
Completed
2,541 enrolled
Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690
Completed
307 enrolled
Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab
Completed
559 enrolled
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia
Completed
257 enrolled
Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397
Completed
42 enrolled
Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia
Completed
186 enrolled
S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911
Completed
180 enrolled
S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
Completed
375 enrolled
Biomarker in Tissue Samples From Patients With Ewing Sarcoma
Completed
40 enrolled
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma
Completed
5 enrolled
Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor
Completed
185 enrolled
Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia
Completed
32 enrolled
Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma
Completed
7 enrolled
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421
Completed
90 enrolled
Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia
Completed
15 enrolled
DNA Biomarkers in Samples From Patients With Osteosarcoma and Healthy Volunteers
Completed
90 enrolled
Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia
Completed
50 enrolled
Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia
Completed
9 enrolled
Biomarkers in Tissue Samples From Young Patients With Liver Cancer
Completed
99 enrolled
Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial
Completed
10 enrolled
Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors
Completed
50 enrolled
Studying Gene Expression and Location in Samples From Patients With Brain Tumors
Completed
10 enrolled
Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia
Completed
150 enrolled
Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma
Completed
23 enrolled
DNA Tests in Detecting Disseminated Disease in Tumor, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma
Completed
170 enrolled
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia
Completed
200 enrolled
Changes in DNA After Radiation Therapy in Patients With Prostate Cancer
Completed
13 enrolled
Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission
Completed
135 enrolled
Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28
Unknown
1,300 enrolled
Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors
Completed
165 enrolled
S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase 2 Withdrawn
Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer
Phase 3 Completed
1,856 enrolled
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil
Completed
750 enrolled
Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45
Withdrawn